Status:
UNKNOWN
Effect of Saccharomyces Boulardii on Indirect Hyperbilirubinemia and Phototherapy Duration in Very Low Birth Weight Infants
Lead Sponsor:
Zekai Tahir Burak Women's Health Research and Education Hospital
Conditions:
Indirect Hyperbilirubinemia
Eligibility:
All Genders
1-15 years
Phase:
PHASE4
Brief Summary
Indirect hyperbilirubinemia is frequently observed in premature infants.Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal system. In this study we aimed to compar...
Eligibility Criteria
Inclusion
- very low birth weight infants
Exclusion
- chromosomal anomalies
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01411761
Start Date
May 1 2011
End Date
December 1 2011
Last Update
August 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zekai Tahir Burak Maternity Teaching Hospital, Division of Neonatology
Ankara, Turkey (Türkiye), 06230